{
    "2019-12-30": [
        [
            {
                "time": "2018-03-21",
                "original_text": "U.S. District Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit",
                "features": {
                    "keywords": [
                        "Court Rules",
                        "Lilly",
                        "Alimta",
                        "Patent Lawsuit"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Phase 3",
                        "Clinical Trial",
                        "RET-Mutant",
                        "Thyroid Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}